Cesar Tovar

1.4k total citations
21 papers, 881 citations indexed

About

Cesar Tovar is a scholar working on Pulmonary and Respiratory Medicine, Microbiology and Oncology. According to data from OpenAlex, Cesar Tovar has authored 21 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 18 papers in Microbiology and 7 papers in Oncology. Recurrent topics in Cesar Tovar's work include Veterinary Oncology Research (19 papers), Microbial infections and disease research (18 papers) and Ear and Head Tumors (7 papers). Cesar Tovar is often cited by papers focused on Veterinary Oncology Research (19 papers), Microbial infections and disease research (18 papers) and Ear and Head Tumors (7 papers). Cesar Tovar collaborates with scholars based in Australia, United Kingdom and Denmark. Cesar Tovar's co-authors include Michael Lockwood, GM Woods, Alexandre Kreiss, A. Bruce Lyons, Hannah V. Siddle, Kate Swift, Elizabeth P. Murchison, Katherine Belov, Jim Kaufman and Jocelyn M. Darby and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Cesar Tovar

21 papers receiving 856 citations

Peers

Cesar Tovar

PRM

MICRO

IMMUN

ONCOL

GENET

Kate Swift Australia

Anne‐Maree Pearse Australia

José M. C. Tubío Spain

Philip O’Brien United Kingdom

Andrew S. Flies Australia

Allison Jones United States

Candice Clarke Australia

Orlando Ribeiro Brazil

Akira Nishikawa Japan

David Strand Norway

Kate Swift Australia

Cesar Tovar

468 ×1.2

PRM

428 ×1.2

MICRO

141 ×0.9

IMMUN

116 ×0.8

ONCOL

237 ×1.7

GENET

Citations per year, relative to Cesar Tovar Cesar Tovar (= 1×) peers Kate Swift

Countries citing papers authored by Cesar Tovar

Since Specialization

Citations

This map shows the geographic impact of Cesar Tovar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cesar Tovar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cesar Tovar more than expected).

Fields of papers citing papers by Cesar Tovar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cesar Tovar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cesar Tovar. The network helps show where Cesar Tovar may publish in the future.

Co-authorship network of co-authors of Cesar Tovar

This figure shows the co-authorship network connecting the top 25 collaborators of Cesar Tovar. A scholar is included among the top collaborators of Cesar Tovar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cesar Tovar. Cesar Tovar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patchett, Amanda L., Cesar Tovar, Nicholas B. Blackburn, GM Woods, & A. Bruce Lyons. (2021). Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials. Immunology and Cell Biology. 99(7). 711–723. 6 indexed citations

Patchett, Amanda L., Tim Coorens, Jocelyn M. Darby, et al.. (2019). Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii). Cellular and Molecular Life Sciences. 77(9). 1847–1858. 23 indexed citations

Coleby, Rachel, Cesar Tovar, Maximilian R. Stammnitz, et al.. (2018). The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer. eLife. 7. 39 indexed citations

Tovar, Cesar, Amanda L. Patchett, Richard Wilson, et al.. (2018). Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease. PLoS ONE. 13(4). e0196469–e0196469. 5 indexed citations

Patchett, Amanda L., Richard Wilson, Jac Charlesworth, et al.. (2018). Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells. Oncotarget. 9(22). 15895–15914. 11 indexed citations

Woods, GM, Samantha Fox, Andrew S. Flies, et al.. (2018). Two Decades of the Impact of Tasmanian Devil Facial Tumor Disease. Integrative and Comparative Biology. 58(6). 1043–1054. 11 indexed citations

Tovar, Cesar, Ruth J. Pye, Alexandre Kreiss, et al.. (2017). Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils. Scientific Reports. 7(1). 43827–43827. 44 indexed citations

Patchett, Amanda L., Cesar Tovar, Lynn M. Corcoran, A. Bruce Lyons, & GM Woods. (2017). The toll-like receptor ligands Hiltonol® (polyICLC) and imiquimod effectively activate antigen-specific immune responses in Tasmanian devils (Sarcophilus harrisii). Developmental & Comparative Immunology. 76. 352–360. 13 indexed citations

Patchett, Amanda L., Jocelyn M. Darby, Cesar Tovar, A. Bruce Lyons, & GM Woods. (2016). The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines. PLoS ONE. 11(12). e0168068–e0168068. 12 indexed citations

10.

Tovar, Cesar, Alexandre Kreiss, Jocelyn M. Darby, et al.. (2016). Mitogen‐activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells. Immunology and Cell Biology. 94(7). 673–679. 16 indexed citations

11.

Patchett, Amanda L., R Latham, Kate H. Brettingham‐Moore, et al.. (2015). Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil. Developmental & Comparative Immunology. 53(1). 123–133. 16 indexed citations

12.

Kreiss, Alexandre, et al.. (2015). Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations. Vaccine. 33(26). 3016–3025. 39 indexed citations

13.

Pye, Ruth J., David Pemberton, Cesar Tovar, et al.. (2015). A second transmissible cancer in Tasmanian devils. Proceedings of the National Academy of Sciences. 113(2). 374–379. 152 indexed citations

14.

Woods, GM, Lauren J. Howson, Cesar Tovar, et al.. (2015). Immunology of a Transmissible Cancer Spreading among Tasmanian Devils. The Journal of Immunology. 195(1). 23–29. 24 indexed citations

15.

Howson, Lauren J., Katrina Morris, T Kobayashi, et al.. (2014). Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors. The Anatomical Record. 297(5). 925–938. 28 indexed citations

16.

Dorantes‐Aranda, Juan José, T. David Waite, Andrew L. Rose, et al.. (2011). Novel application of a fish gill cell line assay to assess ichthyotoxicity of harmful marine microalgae. Harmful Algae. 10(4). 366–373. 56 indexed citations

17.

Tovar, Cesar, D.L. Obendorf, Elizabeth P. Murchison, et al.. (2011). Tumor-Specific Diagnostic Marker for Transmissible Facial Tumors of Tasmanian Devils. Veterinary Pathology. 48(6). 1195–1203. 45 indexed citations

18.

Kreiss, Alexandre, et al.. (2010). A Murine Xenograft Model for a Transmissible Cancer in Tasmanian Devils. Veterinary Pathology. 48(2). 475–481. 22 indexed citations

19.

Murchison, Elizabeth P., Cesar Tovar, Arthur Hsu, et al.. (2009). The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer. Science. 327(5961). 84–87. 4 indexed citations

20.

Tovar, Cesar & Michael Lockwood. (2008). Social impacts of tourism: an Australian regional case study. International Journal of Tourism Research. 10(4). 365–378. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact